Author: Huang Zimin, a reporter of the New Pastoral Network
After experiencing the loss baptism of the whole livestock and poultry industry in 2021, in 2022, the animal husbandry industry began to vigorously promote high-quality development and improve breeding efficiency. African swine fever has changed the fundamentals of China's pig industry, and the degree of intensive breeding of livestock industry has reached the development effect of poultry industry for 5-10 years in the past 3 years, and will develop at a faster speed in the future. The healthy development of the industry sometimes has to go through some pain to form a relatively mature industrial pattern.
Cui Guangchao, vice president of Shandong Xinde Technology Co., Ltd
"Environmental protection and non-plague have accelerated the transformation speed of pig intensification and modernization, and capital support has also spawned an abnormal situation of over-expansion of production capacity, but it is certain that the future pig industry will eventually return to its essence, that is, the competition of efficiency." Cui Guangchao, vice president of Shandong Xinde Technology Co., Ltd. (hereinafter referred to as Xinde Technology), said that at present, everyone pays more attention to improving efficiency through cost reduction, but cost reduction is only one of the important links, and breeding enterprises should pay more attention to consumption changes, industrial synergy and the application of new technologies and new models in order to more calmly cope with future industrial development trends.
In Zhucheng, Shandong, the high-level intelligent manufacturing industrial park of biological products completed by Xinde's new acceptance is mainly based on pig vaccine production. The park includes P3-level large animal room, animal biomedical technology innovation center, veterinary drug biological products research and development and manufacturing project, with a total investment of 700 million yuan, covering an area of 120 acres, is currently one of the largest veterinary biological products production bases in China. The park successfully introduced the production of Shanghai Haili pig vaccine series products. Starting from 2020, Xinde Technology and Shanghai Haili Biotechnology Co., Ltd. (hereinafter referred to as Haili) have achieved strategic cooperation, and Haili Bio's diverse product series and Reliance's perfect sales and service network have been strongly combined. After the cooperation, the livestock sector of the two companies has a more complete product line, a wider range of channels and stronger service capabilities.
Developing products that meet market demand is the key to making Reliance Technology bigger and stronger. Cui Guangchao said that in recent years, the livestock sector of Xinde Technology has been focusing on the bottleneck problems faced in the production process of the pig industry to do product research and development and layout, which focuses on the needs of the industry of "net blue anti-non-proliferation". For the prevention and control of major diseases such as African swine fever, blue ear disease and piglet epidemic diarrhea, Relinder has mastered mature experience. The "pseudo-rabid dog two-step turn yin method" and "ring one needle one service full defense prevention and control plan" have become highly competitive solutions in the industry. Relying on key products, the sales of pig vaccines of Xinde Technology in 2021 increased by more than 70% year-on-year, and in 2022, it will also carry out the two-step action of pseudo-madness to yin, and promote the long-term promotion of two series of products and services such as pseudo-crazy yin and net blue anti-non-yin.
Xinde Technology focused on the poultry business in the early days, and in recent years, it has focused on entering the livestock field, and with the service experience accumulated in the poultry industry, the company quickly opened up the situation in the pig market. Cui Guangchao introduced that for small and medium-sized pig farms, Xinde has joined hands with more than 200 dealers across the country to open up the last kilometer of service. At the same time, in 2019, the company opened an online community "Xinyouhui" to help customers quickly obtain market information through multiple channels and formulate targeted solutions.
For large group customers, Xinde Technology proposed from 2020 to create a marketing strategy of technology integration, integrate the five major enabling departments of research, inspection, production, service and sales, organize expert teams to conduct one-on-one exchanges and services for the problems of users or the long-term needs of future disease purification, and form an integrated strategic cooperative relationship through the five common schemes of data sharing, technical symbiosis, program co-production, result co-evaluation and value sharing.
As the old saying goes, there is a cloud, a good word, a friend's way, but it must be advised and a good way. It means that friends have the responsibility to criticize and supervise each other, but they also need to provide each other with ways to improve by following the rules and methods. Cui Guangchao believes that animal protection enterprises and breeding enterprises are like a pair of friends. Animal protection enterprises help the breeding end to improve efficiency through products, but they cannot over-sell, and they must realistically help customers maximize value. According to this, the reporter of the Agricultural Treasure Book Xinmu Network interviewed Cui Guangchao, vice president of Xinde Technology, to discuss the current development of the pig industry.
New Pastoral Q&A:
1. Reliance covers pigs, poultry animal-related vaccines, biological products and additives, etc., what is the overall layout of The current Reliable Livestock Sector? Such as factories, R & D bases, sales areas, etc.?
Based on the development status and trend of the pig industry in the mainland, as well as the company's strategic development layout, in recent years, Xinde has begun to increase strategic investment in livestock animal protection, successively from the aspects of scientific research and innovation, lean manufacturing, marketing and service team building, etc., currently has three major R & D bases in Qingdao, Beijing and Zhucheng, Beijing Xinde, Shandong Xinde and Sichuan Huaxi and Shandong Xinde animal vaccine four major animal protection production bases, products covering pig vaccines, biochemical products, veterinary drug preparations, feed additives and plant extracts. Focus on the strategy at the sales regional level, with Shandong, Henan, Sichuan, Hebei, Liaoning and other core areas, deep ploughing, focusing on key markets at the district and county levels, paying attention to the needs of large-scale pig farms, and taking the actual needs of customers as the guide.
2. What are the key products of The Trust Livestock Sector, and how is the market performance of swine vaccines in the first half of the year?
In recent years, The Livestock Sector has been designing product development and layout around the bottleneck problems or major sudden diseases faced in the production process of the pig industry, and our strategy in the past 5 years has focused on the net blue anti-non-african, which highlights the demand level of the industry, such as African swine fever, blue ear disease and piglet epidemic diarrhea and other major disease prevention and control, Xinde has mastered and precipitated some mature experience and programs, and the pseudo rabid dog two-step yin method, The ring one needle one service full defense prevention and control program and the blue ear activation + extinction immunity program have become a highly competitive solution in the industry. Based on the high degree of compatibility between our key products and market demand, our sales of swine vaccines in 2021 increased by more than 70% year-on-year.
3. Please introduce the original intention and background of the in-depth cooperation between Xinde and Haili, what advantages and resources of the cooperation between the two sides complement each other, and what synergies are played?
The strategic cooperation between Shandong Xinde and Haili is an inevitable trend in the development of the industry, and it is the practice of complementary advantages, resource integration and strong alliance. Haili Biological is a domestic biological products with early development, product types from breeding stock to commodity generation full coverage, high market visibility, strong influence in the first-line pig farm, belongs to the first-line brand of national brands.
Since its establishment in 1999, Shandong Xinde has been adhering to the concept of unswervingly increasing customer value, taking customer needs as the center, scientific and technological innovation, service innovation and development ideas, actively exploring in the field of marketing and service innovation, and achieving a good reputation.
In 2020, the strategic cooperation with Shanghai Haili Biotech will have a more complete livestock product line, wider channel coverage and stronger service capabilities after cooperation, which will definitely enable the two companies to develop healthily and rapidly in their respective advantageous fields.
4. Since 2021, cost reduction and efficiency improvement are the mainstream voices in the industry, in terms of products and services, what strategies has the company adopted to cope with the current situation changes?
At present, everyone pays more attention to achieving efficiency improvement through cost reduction, but cost reduction is only one of the important links, and everyone should pay more attention to consumption changes, industrial synergy and the innovation of new technologies and new models, so as to cope with future industries and industry development trends as a whole.
Based on this pre-judgment, we adhere to the two-step strategy: first solve the urgent needs of pig farms, from disease detection and sanitation disinfection, to core immunity, help pig farms always understand the dynamics of surrounding diseases and infection pressure, and help pig farms raise pigs well through all-round disinfection programs and conventional basic immunization, which is the biggest cost reduction program. Secondly, in the long run, several major diseases will eventually take the purification route, so the pseudo-rabies two-step yin method launched by Xinde can indeed help pig farms achieve backup yin, and the blue ear inactivated vaccine listed in 2021 and the blue ear mRNA vaccine in research will help pig farms finally achieve the purification of blue ear disease.
In any case, in the future, biosecurity, health care programs, and epidemic prevention programs are the core key tasks of pig farms, and Reliance will also focus on the needs of these three aspects, with the purpose of meeting customer needs, and develop scientific and technological innovation under the double epidemic.
5. Blue ear disease inactivated vaccine is more and more favored by the market, what are the characteristics and advantages of the company's blue ear disease prevention and control Ningjing plan?
The main problem of live vaccines now is safety, and there is no problem with the safety of inactivated vaccines, but the effectiveness is an industry problem. Ningjing plans to be verified by several large group companies in the north and south, proving that the live vaccine Xinlaning is a high-blue vaccine with very high safety at present, and Xinlanjing effectively solves the ADE phenomenon and effectively solves the antibody dependence by improving the antigen content and purity, and ensures the effectiveness of the product. In this way, the combination of live and extinguishing organically combines safety and efficacy; at the same time, it is believed to have a complete drug product line, and at the same time, it can provide complete solutions for different customers while immunization.
The combination of "Xinlan ning + Xinlanjing" is the mainstream immunization model for the prevention and control of blue ear disease in the next 3-5 years, but the program must be changed according to the pressure and demand of blue ear disease infection in pig farms, through the transition of such a program, gradually reduce or even stop the use of blue ear live seedlings, and then gradually reduce the use of inactivated vaccines until the transition to non-immunity to achieve blue ear purification.
6. Now that the competition in the animal insurance industry is becoming more and more fierce, how will the company improve the competitive strength and anti-risk ability of the veterinary vaccine business?
At present, the production capacity of the animal protection industry is excessive, in this context, fierce competition and even fierce competition will be an inevitable phenomenon, so the next five years of animal insurance pattern will undergo major changes, the industry's head enterprises rapid expansion, market segments are not lack of excellent enterprise focus. Mergers and acquisitions, integration and mergers and acquisitions occur from time to time, so everyone is also building core competitiveness in order to stand out in the new round of competition.
Anti-risk ability is a systematic ability, we have a clear goal is to go all out to solve customer problems, based on biosecurity, health care programs, immunization programs of the three major needs, close to the terminal, lean manufacturing, from the service system, sales system, research and development system, production system, market system five major plates to forge the ability of enterprises to solve problems, escort for the aquaculture industry. The company adheres to long-term doctrine and continuously contributes to the healthy development of the aquaculture industry. Reliance's core business philosophy is to unswervingly increase customer value.